MUMBAI, India, July 31 -- Intellectual Property India has published a patent application (202617067463 A) filed by Akebia Therapeutics, Inc. on May 29, 2026, for Treatment Of Anca-Associated Vasculitis.
Inventors include Campagna, Jason; Violette, Shelia, Marie; and Wu, Hong.
The application for the patent was published on July 24, 2026, under issue no. 30/2026.
Abstract: Provided are compounds, compositions and methods for treating ANCA-Associated Vasculitis (AA V) in patients in need thereof, the method comprising administering an effective amount of a composition comprising a fusion protein construct comprising: an antibody that specifically binds to complement protein 3d (c3d), and two complement modulator polypeptides each comprising a biologically active fragment of factor H.
Disclaimer: Curated by HT Syndication.
